Titan International (TWI) – A Solid Start to the Year


Friday, May 01, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Overview. Titan’s first quarter 2026 results came in at the high end of management’s expectations and above our projections, partly driven by positive forex. Titan achieved this performance against a macro backdrop that continues to be very dynamic. Once again, EMC was the star performer with revenue up 11.3% year-over-year and gross margin up 90 basis points. With a diversified portfolio of products, strategically positioned global plants, and a one-stop shop distribution channel, we believe Titan is well-positioned for today’s dynamic operating environment.

1Q26 Results. Revenue of $505 million was up 2.9% y-o-y and exceeded our $495 million projection. The revenue increase was driven by forex gains, which added approximately 3.7% to net sales growth. Gross margin improved to 14.1% from 14.0%. Adjusted EBITDA totaled $31.4 million, up from $30.8 million a year ago and our $26 million estimate. Titan reported adjusted EPS of breakeven versus adjusted EPS of $0.01 last year and our $0.03 estimate.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

NN (NNBR) – CARES Act Refund


Friday, May 01, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Refund. NN announced that the Company has been notified that its CARES Act refund has been processed for payment. The refund is in excess of $10 million. This refund has been a long time in coming, but will help the Company in its growth efforts, in our view.

Growth Opportunity. The tax refund will more than offset the $10 million the Company borrowed in 1Q26 to fund certain growth areas with both capital equipment and working capital. While it is too soon to say which path the Company will follow, the tax refund could enable to further boost the abundant growth opportunities through additional investment or repay the 1Q26 borrowing.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Euroseas (ESEA) – Fleet Expansion Strengthens Long-Term Earnings Visibility


Friday, May 01, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Euroseas expands its fleet. The company has ordered four additional feeder containerships, including two high-reefer vessels and two standard feeder ships, bringing its total newbuild program to ten vessels with a combined cost of about $500 million. Upon completion of the current newbuild program, Euroseas will operate 31 vessels with a total capacity of 93,834 twenty-foot equivalent units (TEU). The expansion reflects confidence in the feeder market and a deliberate focus on higher value cargo segments, particularly refrigerated goods, while also incorporating optionality for further fleet growth.

Strong earnings visibility. With a contracted revenue backlog of roughly $650 million and charter coverage extending beyond 2028, the company has secured a high level of earnings visibility. The current fleet is largely employed under time charter agreements at favorable rates, reducing exposure to market volatility and supporting stable cash flow generation to fund ongoing expansion.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Cadrenal Therapeutics (CVKD) – Preliminary Design For CAD-1005 Phase 3 In HIT Announced


Friday, May 01, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Phase 3 Design Announced. Cadrenal held an end-of-Phase-2 meeting with the FDA to discuss the results of the CAD-1005 trial and receive guidance for the design of Phase 3. Following the receipt of the Meeting Minutes, the preliminary design for Phase 3 in HIT (Heparin-Induced Thrombocytopenia) has been announced. The trial is expected to begin in late FY2026 to early FY2027, with an NDA possible in FY2019.

HIT Is A Serious Condition. HIT is a potentially life-threatening immune reaction to heparin, an anticoagulant currently used in an estimated 12 million cardiac surgeries. HIT affects up to 5% of these patients, forming immune complexes that can activate platelets and cause excessive clotting. About 50% experience thrombosis, as well as embolisms, skin necrosis, and other cardiac events that can be fatal. CAD-1005 is a selective inhibitor of the 12-LOX immune pathway that causes HIT. This contrasts with other drugs that control symptoms and secondary morbidities following the immune response.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Belden Bets $1.85 Billion on RUCKUS Networks to Become a Full-Stack IT/OT Powerhouse

Belden Inc. (NYSE: BDC) is making its biggest strategic push in years. The St. Louis-based specialty networking solutions provider announced Wednesday it has signed a definitive agreement to acquire RUCKUS Networks from Vistance Networks (Nasdaq: VISN) for approximately $1.85 billion in a debt-financed transaction that fundamentally reshapes what Belden is — and who it competes against.

The deal adds capabilities Belden simply doesn’t have today: enterprise-grade Wi-Fi and switching technology. For a company that has long been the infrastructure layer — the cables, connectors, and passive components behind enterprise and industrial networks — acquiring RUCKUS is a direct move up the stack.

What Belden Is Buying

RUCKUS is not a niche player. The company serves more than 48,000 customers globally with an integrated portfolio spanning Wi-Fi, enterprise switching, and an AI-driven cloud networking platform. Its sweet spots are high-density, mission-critical environments — hospitality, education, and healthcare — exactly the verticals where Belden already has customer relationships and distribution reach.

That overlap is the deal’s core thesis. Belden walks into existing customer accounts and can now offer a complete end-to-end networking solution rather than handing off business to competitors at the active networking layer. The cross-sell opportunity is immediate and doesn’t require building new channels from scratch.

The industrial angle is equally compelling. As manufacturers and industrial operators accelerate the convergence of their IT and OT environments — connecting factory floors to enterprise networks — demand for high-performance wireless and switching in industrial settings is rising sharply. RUCKUS gives Belden a proven platform to chase that opportunity.

The Financial Case

At approximately 13x projected 2026 adjusted EBITDA, Belden is paying a growth multiple, but the numbers justify the premium. RUCKUS comes in with high-single-digit revenue growth, gross margins above 60%, and adjusted EBITDA margins above 20% — all meaningfully better than Belden’s current profile. The transaction is expected to be immediately accretive to adjusted earnings per share and expand both gross and EBITDA margins in the first full year of ownership.

The combined adjusted EBITDA base is projected at approximately $650 million, which gives Belden a meaningful cash generation engine to attack the debt load. J.P. Morgan has provided fully committed debt financing, and Belden expects to bring net leverage below 3.0x within the first full year post-close, targeting approximately 1.5x by 2029. Share repurchases will be paused until leverage is closer to that long-term target — a responsible trade-off given the size of the bet.

The Bigger Picture

This acquisition is Belden making a definitive statement about what it wants to be. The company has spent years positioning around industrial and enterprise connectivity, but selling passive networking infrastructure in a world moving toward software-defined, cloud-managed networking was increasingly a commodity play. RUCKUS changes that equation.

Bringing an AI-driven cloud networking platform under the Belden umbrella alongside established hardware capabilities creates a more defensible, higher-value business. Customers increasingly want fewer vendors and more complete solutions — Belden is positioning itself to be that vendor.

Both boards have approved the transaction. Close is expected in the second half of 2026, pending regulatory approvals.